We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-4.88%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$217M
AUM Growth
+$14.7M
(+7.3%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
31.84%
Holding
169
New
34
Increased
48
Reduced
19
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TGAN
Transphorm, Inc. Common Stock
TGAN
|
+$4.28M |
| 2 |
Essex Property Trust
ESS
|
+$4.25M |
| 3 |
CAMP
CalAmp Corp.
CAMP
|
+$2.92M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantronix
LTRX
|
+$1.24M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.24M |
| 3 |
OIIM
02Micro International
OIIM
|
+$1.11M |
| 4 |
FOCL
EDAP TMS S.A.
FOCL
|
+$1.03M |
| 5 |
Simon Property Group
SPG
|
+$847K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.37% |
| 2 | Healthcare | 10.03% |
| 3 | Financials | 4.46% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Real Estate | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Annaly Capital Management
NLY
$17.1B
| – | – |
-6,725
| Closed | -$210K |
|
127
NeuroOne Medical Technologies
NMTC
$14.4M
| – | – |
-18,161
| Closed | -$211K |
|
128
NVE Corp
NVEC
$613M
| – | – |
-10,893
| Closed | -$744K |
|
|
129
Simon Property Group
SPG
$72.9B
| – | – |
-5,300
| Closed | -$847K |
|
|
ALIM
130
DELISTED
Alimera Sciences
ALIM
| – | – |
-123,947
| Closed | -$636K |
|
|
CASA
131
PUT
DELISTED
Casa Systems, Inc. Common Stock
CASA
| – | – |
-16,400
| Closed | -$31K |
|
|
ICPT
132
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-38,300
| Closed | -$15K |
|
|
OIIM
133
DELISTED
02Micro International
OIIM
| – | – |
-245,608
| Closed | -$1.11M |
|
|
HTGM
134
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| – | – |
-11,928
| Closed | -$776K |
|
|
ALNA
135
DELISTED
Allena Pharmaceuticals
ALNA
| – | – |
-980,200
| Closed | -$581K |
|
|
VCRA
136
PUT
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| – | – |
-12,100
| Closed | -$8K |
|
|
EMKR
137
DELISTED
Emcore Corp
EMKR
| – | – |
-8,789
| Closed | -$614K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Worth Venture Partners held 169 positions worth $217M, up 7.3% from $202M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Worth Venture Partners withdrew a net $10.7M in Q1 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Lantronix, an estimated $1.24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Transphorm, Inc. Common Stock worth $4.31M.
- Worth Venture Partners's largest Q1 2022 buy was Transphorm, Inc. Common Stock: 609,170 shares worth $4.31M.
- Worth Venture Partners added most to DZS Inc. Common Stock in Q1 2022, an estimated $1.72M increase.
- Worth Venture Partners's biggest Q1 2022 reduction was EDAP TMS S.A., cutting an estimated $1.03M.
- Worth Venture Partners fully exited Lantronix in Q1 2022, selling an estimated $1.24M.
- Worth Venture Partners's ten largest holdings make up 32% of its $217M portfolio in Q1 2022.
- Worth Venture Partners opened 34 new positions and closed 23 in Q1 2022.
- Worth Venture Partners's portfolio value rose 7.3% quarter-over-quarter to $217M.
Based on Worth Venture Partners's 13F filing for Q1 2022, filed 16 May 2022.